Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.0850
0.00 (0.00%)
Oct 1, 2026, 3:25 PM EST
Ventripoint Diagnostics Revenue
Ventripoint Diagnostics had revenue of 19.58K CAD in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 247.77K, up 23.68% year-over-year. In the year 2025, Ventripoint Diagnostics had annual revenue of 179.93K with 89.06% growth.
Revenue (ttm)
247.77K
Revenue Growth
+23.68%
P/S Ratio
110.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
16.39M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 179.93K | 84.76K | 89.06% |
| Dec 31, 2024 | 95.17K | 45.99K | 93.51% |
| Dec 31, 2023 | 49.18K | -18.98K | -27.85% |
| Dec 31, 2022 | 68.17K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 36.02K | -45.01K | -55.55% |
| Dec 31, 2019 | 81.02K | 20.85K | 34.64% |
| Dec 31, 2018 | 60.18K | 21.27K | 54.68% |
| Dec 31, 2017 | 38.91K | -170.57K | -81.43% |
| Dec 31, 2016 | 209.48K | 158.18K | 308.38% |
| Dec 31, 2015 | 51.30K | -77.16K | -60.07% |
| Dec 31, 2014 | 128.45K | 57.51K | 81.05% |
| Dec 31, 2013 | 70.95K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 24.92M |
| Perimeter Medical Imaging AI | 3.03M |
| Cheelcare | 2.32M |
| Conavi Medical | 845.00K |
| Theralase Technologies | 802.46K |
| Frequency Exchange | 647.43K |
| MedX Health | 569.79K |
| NuGen Medical Devices | 148.72K |
Ventripoint Diagnostics News
- 8 days ago - Ventripoint Announces Successful Completion of Annual Quality and Regulatory Audits - TheNewswire
- 18 days ago - Ventripoint Issues Shares for Payment of Debenture Interest - TheNewswire
- 24 days ago - Ventripoint Closes First Tranche of Private Placement Financing and Engages Strategic Advisors to Accelerate Commercialization of VMS+™ Technology - TheNewswire
- 4 weeks ago - Ventripoint Diagnostics Registration statement: Q2 2026 - Filings
- 4 weeks ago - Ventripoint Diagnostics Registration statement: Q2 2026 - Filings
- 6 weeks ago - UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform - Accesswire
- 7 weeks ago - Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging - GlobeNewsWire
- 7 weeks ago - Ventripoint Diagnostics Announces Cancellation and Re-Grant of Options, Grant of Annual Incentive Options and Private Placement - TheNewswire